Prosecution Insights
Last updated: August 06, 2026

Saul Ewing LLP (Philadelphia)

155 pending office actions • 63 clients • 141 examiners • 83 art units • 0 of 155 (0%) have an AI response strategy ready

Quality Metrics (n=5399 apps, methodology: how we score firms)

81.7%
Allowance Rate
n=5399
+0.67σ
Allowance Rate (norm)
n=5399
3.9
OAs to Allowance
n=2478
+0.01σ
OAs to Allow (norm)
n=2478
1107 days
Time to Allowance
n=2478
+17.1pp
Interview Lift
n=5399
31.7%
RCE Rate
n=5399
1.4%
Appeal Rate
n=5399

Rejection Performance (% of received rejections ultimately overcome)

72.4%
§101 Overcome
n=463
73.7%
§102 Overcome
n=1215
76.2%
§103 Overcome
n=1987
78.2%
§112 Overcome
n=1815

Specialization & Scale

A61K, A61P, C12N
Top CPC Subclasses
28%
Top-3 CPC Share
n=5399
0
Practitioners
n=5399
Apps / Practitioner
n=5399 (min 20)

Portfolio Summary

155
Total Pending OAs
103
Non-Final OAs
50
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 60 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

33
Overdue
0
Due this week
14
Due this month
7
Due in next 60 days
6
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 60 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (33)Due ≤ 30 days (14)Due ≤ 60 days (7)Due later (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

78
Hard (50%)
57
Medium (37%)
18
Easy (12%)
2
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only4 (3%)
§101 + other16 (10%)
§103 only33 (21%)
§102 only5 (3%)
§112 only15 (10%)
Double-patenting only3 (2%)
Double-patenting + other19 (12%)
Multi-statute (no §101)58 (37%)
No statute on record2 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

106
Life Sciences
68% of docket
4
Information Tech
3% of docket
8
Communications
5% of docket
2
Semiconductors
1% of docket
21
Mechanical / Eng
14% of docket
14
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,550 h
Manual time on pending OAs
310 h
Time saved (low, 20%)
542 h
Time saved (mid, 35%)
13.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YEN, ERIC L 4 85.1% +11.7%
KELLY, ROBERT M 3 73.7% +24.8%
SCHMITT, MICHAEL J 3 56.6% +21.7%
YAARY, ERIC 2 73.7% +3.2%
GREENE, CAROLYN LEE 2 65.2% +49.4%
EDGINGTONGIORDANO, FRANCESCA 2 71.8% +30.6%
RAMIREZ, DELIA M 2 65.1% +56.3%
CHEN, STACY BROWN 2 66.1% +40.2%
CHERNYSHEV, OLGA N 2 54.5% +34.2%
HIBSHMAN, SARAH GRACE 2 39.6% +43.0%

Quick Wins (4)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L
19397080 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L
19389287 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L
19383139 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL YEN, ERIC L

Hard Cases (78)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17222216 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS WHICH RELATE TO TRAVEL ARRANGEMENTS WALSH, EMMETT K 79d overdue
17761020 METHODS OF TREATING PHOSPHATE CONCENTRATION DISORDERS WITH L-BAIBA DAHLIN, HEATHER RAQUEL 77d overdue
17646581 PROTEIN STABILIZED LIPOSOMES (PSL) AND METHODS OF MAKING THEREOF CRUM, MARY ABOU NADER 77d overdue
18997039 VIDEO ENCODING AND DECODING CHANG, DANIEL 45d overdue
17768166 TARGETED BIFUNCTIONAL DEGRADERS GOTFREDSON, GAREN 30d overdue
18276582 CCR4-Targeting Chimeric Antigen Receptor Cell Therapy EDGINGTONGIORDANO, FRANCESCA 23d overdue
17654984 ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS HIBSHMAN, SARAH GRACE 23d overdue
17928228 WAX-LIKE FORMULATIONS OF NATURAL-ORIGIN MATERIALS AND ITS METHOD OF PREPARATION LIOTT, CAROLINE DUSHECK 22d overdue

Interview Candidates (22)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18431638 COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS KELLY, ROBERT M 97d overdue
17768145 ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS HIBSHMAN, SARAH GRACE 70d overdue
17602949 Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins EDGINGTONGIORDANO, FRANCESCA 37d overdue
18304843 Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias KELLY, ROBERT M 26d overdue
18276582 CCR4-Targeting Chimeric Antigen Receptor Cell Therapy EDGINGTONGIORDANO, FRANCESCA 23d overdue
17654984 ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS HIBSHMAN, SARAH GRACE 23d overdue
18446296 Bi-functional Molecules To Degrade Circulating Proteins SCHMITT, MICHAEL J 14d
17756212 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY SCHMITT, MICHAEL J 20d

Client Portfolio (63 clients)

Top Art Units

Art UnitApps
16296
26585
16265
16324
16384
16434
16583
16933
16553
16223

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19396998 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA Pending Nov 21, 2025
19397080 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA Pending Nov 21, 2025
19389287 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA Pending Nov 14, 2025
19383139 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, INCLUDING USE OF A LARGE LANGUAGE MODEL UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED YEN, ERIC L 2658 §112 Non-Final OA Pending Nov 07, 2025
19376447 SYSTEMS AND METHODS FOR A PERMISSIONLESS DECENTRALIZED VIRTUAL ASSET NETWORK Pylons, Inc. ASGARI, SIMA 3698 §101§103 Non-Final OA Pending Oct 31, 2025
19342547 COMPUTER IMPLEMENTED METHODS FOR THE AUTOMATED ANALYSIS OR USE OF DATA, AND RELATED SYSTEMS UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED BHATNAGAR, ANAND P 2668 §101§102§103 Final Rejection 21d Pending Sep 27, 2025
19287313 SYSTEMS AND METHODS FOR A PERMISSIONLESS DECENTRALIZED VIRTUAL ASSET NETWORK Pylons, Inc. RAZA, ZEHRA §103 Non-Final OA Pending Jul 31, 2025
19259040 BROWSING METHODS, COMPUTER PROGRAM PRODUCTS, SERVERS AND SYSTEMS Skyscanner Technology Limited HASAN, SYED HAROON §101§102§103§112Other Non-Final OA Pending Jul 03, 2025
19098726 SYSTEM AND METHOD FOR MONITORING A DWELLING Mwc Family LP PENDLETON, DIONNE §102§103 Non-Final OA Pending Apr 02, 2025
19043981 POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY AND PREPARATION METHOD THEREFOR BEIJING EASPRING MATERIAL TECHNOLOGY CO., LTD. APPLEGATE, SARAH ARIMINTIA 1725 §103 Non-Final OA Pending Feb 03, 2025
18997039 VIDEO ENCODING AND DECODING BLACKBIRD PLC CHANG, DANIEL 2487 §101§103 Non-Final OA 45d overdue Pending Jan 18, 2025
19029666 E-CIGARETTE PERSONAL VAPORIZER Ayr Ltd. YAARY, ERIC 1755 §102§103§112 Non-Final OA Pending Jan 17, 2025
18990832 NON-PNEUMATIC TIRE AND METHOD OF MANUFACTURE THEREOF The Carlstar Group LLC BELLINGER, JASON R 3615 §103§112DP Non-Final OA Pending Dec 20, 2024
18987814 METHODS OF INCORPORATING SPORADIC OBJECTS ONTO AN EXISTING MESH Yale University SUO, JOSHUA JUNGWOOK §103 Non-Final OA Pending Dec 19, 2024
18853928 SYSTEMS AND METHODS FOR CONDUCTING REMOTE NEURO-OPHTHALMIC EXAMINATIONS ON A MOBILE DEVICE Thomas Jefferson University BALAJI, KAVYA SHOBANA §102§103§112 Non-Final OA Pending Oct 03, 2024
18904642 SYSTEMS AND METHODS FOR INTERCONNECTING MANUFACTURING NODES AND CONSUMER END POINTS Global Sourcing Network LLC JEANTY, ROMAIN 3624 §101§102 Non-Final OA 62d Pending Oct 02, 2024
18892956 DYNAMIC WALL FOR AUGMENTED REALITY Thomas Jefferson University SANZ, GABRIEL A §103 Non-Final OA Pending Sep 23, 2024
18840040 METHODS OF TREATING, AMELIORATING, OR PREVENTING HEART FAILURE, AND METHODS OF PROMOTING HEART MUSCLE GROWTH Yale University WHITE, DAWANNA SHAR-DAY §102§103§112 Non-Final OA Pending Aug 20, 2024
18794181 AMNIOTIC MEMBRANE POWDER AND ITS USE IN WOUND HEALING AND TISSUE ENGINEERING CONSTRUCTS Wake Forest University Health Sciences COFFA, SERGIO 1658 §103DP Non-Final OA Pending Aug 05, 2024
18790607 Protein Capture Membrane and Method of Use Thereof Yale University BRAZIN, JACQUELINE 1798 §102§103 Non-Final OA 9d overdue Pending Jul 31, 2024
18724520 METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING STRESS-RELATED DISORDER Yale University CORNET, JEAN P §103§112 Non-Final OA Pending Jun 26, 2024
18723210 SYSTEMS AND METHODS FOR GENERATING NEURO-OPHTHALMIC EXAMINATIONS Thomas Jefferson University SIPES, JOHN CURTIS 2872 §101§103 Non-Final OA 8d Pending Jun 21, 2024
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases The United States Department of Veterans Affairs LEE, CHIHYI NMN 1628 §103§112 Final Rejection 34d Pending Jun 21, 2024
18723103 SYSTEMS, DEVICES, AND METHODS FOR IMPLEMENTING COMPUTERIZED AMSLER GRID FOR EVALUATION OF VISUAL DISTURBANCES Stephane Krumenacker BROOME, SHARRIEF I 3792 §102§112 Non-Final OA Pending Jun 21, 2024
18720823 COMPUTER-IMPLEMENTED METHODS AND ASSOCIATED SYSTEMS FOR DETECTING MALIGNANCY The Trustees of the University of Pennsylvania JACOB, OOMMEN 3797 §112 Non-Final OA 33d Pending Jun 17, 2024
18673752 METHODS OF MODIFYING CELLULOSE CRYSTALLINITY Rowan University LAU, JONATHAN S 1693 §102§112 Non-Final OA 18d overdue Pending May 24, 2024
18670290 COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES The Trustees of the University of Pennsylvania LEONARD, ARTHUR S DP Non-Final OA Pending May 21, 2024
18710640 UNDERGLYCOSYLATED KALLIKREIN I, AND POLYETHYLENE GLYCOL MODIFIER THEREOF AND PHARMACEUTICAL USE THEREOF Zonhon Biopharma Institute, Inc. SPANGLER, JOSEPH RANKIN 1656 §101§102§103§112 Non-Final OA Pending May 16, 2024
18706936 SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR THERAPEUTIC EUS ANCHOR Thomas Jefferson University FRITH, SEAN A 3798 §103 Non-Final OA 49d overdue Pending May 02, 2024
18648749 METHODS, SYSTEMS AND COMPOSITIONS FOR NORMOTHERMIC EX VIVO PRESERVATION OF INTACT ORGANS Yale University KOSAR, AARON J 1655 DP Non-Final OA Pending Apr 29, 2024
18644807 DNA mapping and sequencing on linearized DNA molecules Drexel University GREENE, CAROLYN LEE 1758 §103§112 Non-Final OA Pending Apr 24, 2024
18643019 COMPOSITIONS AND METHODS FOR BREWING SOUR BEER Saint Joseph'S University KOHLER, STEPHANIE A 1791 §102§103Other Non-Final OA 13d Pending Apr 23, 2024
18635885 USE OF ICOS-BASED CARS TO ENHANCE ANTITUMOR ACTIVITY AND CAR PERSISTENCE The Trustees of the University of Pennsylvania BERTOGLIO, VALARIE E 1632 §112Other Non-Final OA Pending Apr 15, 2024
18631383 ADJUSTABLE INFANT TUB Tomy International, Inc. DEERY, ERIN LEAH 3754 §103 Non-Final OA 38d overdue Pending Apr 10, 2024
18695471 LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF The Trustees of the University of Pennsylvania ALAM, AYAAN A 1611 §102§103Other Non-Final OA Pending Mar 26, 2024
18693056 PROCESS FOR EMBEDDING A DIGITAL WATERMARK IN TOKENISED DATA Privitar Limited KING, JOHN B 2498 §112 Final Rejection Pending Mar 18, 2024
18692064 COMPOSITION FOR TREATING, PREVENTING, OR AMELIORATING MELANOMA AND METHOD THEREOF Thomas Jefferson University DEKARSKE, MADELINE MCGUIRE 1622 §103 Non-Final OA Pending Mar 14, 2024
18687028 METHOD OF EDITING A VIDEO FILE BLACKBIRD PLC SHIBEROU, MAHELET 2171 §103 Non-Final OA 49d overdue Pending Feb 27, 2024
18444024 COMPOSITIONS, SYSTEMS AND METHODS FOR ENZYME OPTIMIZATION 10X Genomics, Inc. GREENE, CAROLYN LEE §112 Non-Final OA Pending Feb 16, 2024
18684563 TREATMENT COMPOSITIONS AND METHODS The United States Department of Veterans Affairs HEASLEY, MEGHAN CHRISTINE 1626 §102§103§112 Non-Final OA Pending Feb 16, 2024
18684124 COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY Yale University GRASER, JENNIFER E 1645 §101§102§103§112DP Non-Final OA Pending Feb 15, 2024
18431638 COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS The Trustees of the University of Pennsylvania KELLY, ROBERT M 1657 §103Other Final Rejection 97d overdue Pending Feb 02, 2024
18294467 NERVE COUPLER AND METHOD FOR USE OF THE SAME The United States Department of Veterans Affairs ADAM, MOHAMMED SOHAIL 3771 §103§112 Non-Final OA Pending Feb 01, 2024
18293711 DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR The Trustees of the University of Pennsylvania CORDAS, EMILY ANN 1632 §103 Non-Final OA Pending Jan 30, 2024
18292247 COMPOSITIONS AND METHODS FOR ENHANCING CAR T CELL EFFICACY THROUGH THE ENGINEERED SECRETION OF C. PERFRINGENS NEURAMINIDASE The Trustees of the University of Pennsylvania METCALF, MATTHEW CURRAN §102§103§112 Non-Final OA Pending Jan 25, 2024
18417617 COMPOSITIONS AND METHODS FOR SPATIAL AND TEMPORAL CONTROL OF NEUROTROPHIC GROWTH FACTOR EXPRESSION The United States Department of Veterans Affairs AMICK, THOMAS RUSSE 1638 §102§103 Non-Final OA Pending Jan 19, 2024
18573728 COMPOSITIONS AND METHODS FOR PERMEABILIZING THE BLOOD BRAIN BARRIER INSERM HOPKINS, SAMANTHA LAKE §103 Non-Final OA Pending Dec 22, 2023
18528873 NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF Rutgers, The State University Of New Jersey AL-AWADI, DANAH J 1615 §102§103§112Other Non-Final OA 41d Pending Dec 05, 2023
18566373 Tissue-Engineered Rostral Migratory Stream for Neuronal Replacement The United States Department of Veterans Affairs PYLA, EVELYN Y 1633 §102§103§112 Non-Final OA Pending Dec 01, 2023
18565565 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME Compass Pathfinder Ltd. JACKSON, SHAWQUIA 1626 §102§112 Non-Final OA Pending Nov 30, 2023
18562321 METHOD OF MANUFACTURING A MICROSTRUCTURE Memsstar Limited DUCLAIR, STEPHANIE P. 1713 §102§103 Final Rejection Pending Nov 19, 2023
18387669 SYSTEMS AND METHODS FOR METABOLOME ANALYSIS 10X Genomics, Inc. FLINDERS, JEREMY C §102DP Non-Final OA Pending Nov 07, 2023
18559090 METHODS FOR MAKING FERMENTED FOOD AND BEVERAGE PRODUCTS USING GY7B YEAST Saint Joseph'S University GWARTNEY, ELIZABETH A 1759 §103 Non-Final OA 4d overdue Pending Nov 06, 2023
18501859 Methods and Compositions for Treating, Ameliorating, and/or Preventing Chronic Kidney Disease (CKD) and Complications thereof by Regulating DPEP1, CASP9, ACSS2 and/or FASN The Trustees of the University of Pennsylvania VYAS, KEYUR ANILKUMAR 1637 §102§112 Non-Final OA Pending Nov 03, 2023
18500544 E-CIGARETTE PERSONAL VAPORIZER Ayr Ltd. YAARY, ERIC 1755 §103 Non-Final OA 15d Pending Nov 02, 2023
18557449 SYNTHESIS OF CBN AND CBNV Teewinot Life Sciences Corporation COUGHLIN, MATTHEW P 1626 §103§112 Non-Final OA 61d Pending Oct 26, 2023
18557099 SYSTEMS AND METHODS FOR FIBER ZONE-DRAWING AND/OR ZONE-ANNEALING Rowan University LIU, XUE H 1742 §103 Non-Final OA Pending Oct 25, 2023
18555214 METHODS TO DETERMINE TREATMENT EFFICACY WITH GAMMA-DELTA T CELLS The Trustees of the University of Pennsylvania LANDSMAN, ROBERT S 1647 §103 Non-Final OA Pending Oct 12, 2023
18285889 NON-PNEUMATIC TIRE WITH MULTI ANGLE TENSION CONTROL REINFORCEMENTS The Carlstar Group LLC KOTTER, KIP T 3615 §102§103 Final Rejection Pending Oct 06, 2023
18554134 SYSTEMS AND METHODS FOR FRAUD PREVENTION Rewire Holding Ltd. VIG, NARESH 3622 §101§103 Final Rejection 17d overdue Pending Oct 05, 2023
18477584 Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific Antibody The Trustees of the University of Pennsylvania SANG, HONG 1646 §112DP Non-Final OA Pending Sep 29, 2023
18043436 N-Linked Glycosylation Inhibitors and Methods of Using Same Yale University WEDDINGTON, KEVIN E 1629 §102Other Non-Final OA 34d Pending Sep 22, 2023
18368780 PRESERVATIVE COMPOSITIONS Dermegen Inc. COHEN, MICHAEL P 1612 §103 Final Rejection 34d Pending Sep 15, 2023
18467223 METHODS AND COMPOSITIONS FOR GENE EDITING IN HEMATOPOIETIC STEM CELLS The Trustees of the University of Pennsylvania KELLY, ROBERT M 1638 §102§112Other Non-Final OA Pending Sep 14, 2023
18464727 USB DEVICE Arkeytyp Ip Limited BARTELS, CHRISTOPHER A. 2184 §103 Non-Final OA Pending Sep 11, 2023
18549252 COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING T CELL DYSFUNCTION The Trustees of the University of Pennsylvania PERSONS, JENNA L 1637 §101§102§103§112 Non-Final OA Pending Sep 06, 2023
18548481 TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES The Trustees of the University of Pennsylvania LEE, YIE CHIA 1642 §103 Final Rejection 71d overdue Pending Aug 30, 2023
18278932 STERICALLY HINDERED N-ALIPHATIC N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME Rutgers, The State University Of New Jersey KUMAR, SRILAKSHMI K 1738 §102 Final Rejection 22d Pending Aug 25, 2023
18278947 UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME Rutgers, The State University Of New Jersey HUI, SAN MING R 1627 §102§103 Non-Final OA 62d Pending Aug 25, 2023
18276582 CCR4-Targeting Chimeric Antigen Receptor Cell Therapy Nationial Cancer Center EDGINGTONGIORDANO, FRANCESCA 1643 §102§103§112 Non-Final OA 23d overdue Pending Aug 09, 2023
18446296 Bi-functional Molecules To Degrade Circulating Proteins Yale University SCHMITT, MICHAEL J 1629 Other Non-Final OA 14d Pending Aug 08, 2023
18274514 Compounds and Methods for Preventing, Treating, or Ameliorating Airway Disease The Wistar Institute WARD, PAUL V 1622 §112 Non-Final OA Pending Jul 27, 2023
18262037 BET SUBFAMILY INHIBITORS AND METHODS USING SAME BAYLOR COLLEGE OF MEDICINE RAO, PADMAJA S 1627 §102§112 Non-Final OA Pending Jul 19, 2023
18354428 COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY Yale University RAMIREZ, DELIA M 1652 §103§112Other Final Rejection Pending Jul 18, 2023
18354345 COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID Food And Drug Administration SONG, JIANFENG 1613 §103DP Final Rejection 39d Pending Jul 18, 2023
18272486 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS Thomas Jefferson University SCHMITT, MICHAEL J 1629 §102§112 Non-Final OA Pending Jul 14, 2023
18258483 SYSTEMS AND METHODS FOR LATENCY-TOLERANT ASSISTANCE OF AUTONOMOUS VEHICLES Robocars Inc. REFAI, RAMSEY 3664 §102 Non-Final OA Pending Jun 20, 2023
18268125 COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM ESPINOSA, CLAUDIA EDILMA 1654 §103§112 Non-Final OA Pending Jun 16, 2023
18267348 COMPOSITION FOR REVERSIBLE POLYMERIZATION OF THIOESTER AND METHODS THEREOF The Regents of the University of Colorado KAHN, RACHEL 1766 §102§103§112 Non-Final OA Pending Jun 14, 2023
18332150 USE OF CART19 TO DEPLETE NORMAL B CELLS TO INDUCE TOLERANCE The Trustees of the University of Pennsylvania CHANDRA, GYAN 1674 Other Non-Final OA 5d overdue Pending Jun 09, 2023
18322395 PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT Pfizer, Inc. HAMA, JOANNE 1647 §103§112Other Non-Final OA 17d overdue Pending May 23, 2023
18321429 LIPID-BASED NANOPARTICLES AND USE OF SAME IN OPTIMIZED INSULIN DOSING REGIMENS Sdg, Inc. RONEY, CELESTE A 1612 §112DP Non-Final OA Pending May 22, 2023
18250779 REPLICATION-DEFECTIVE VACCINES AND USES THEREOF Rutgers, The State University Of New Jersey CHEN, STACY BROWN 1672 §102§103§112 Non-Final OA Pending May 05, 2023
18034720 GENE SHUFFLED LYSSAVIRUS VACCINE Thomas Jefferson University CHEN, STACY BROWN 1672 §102§103§112 Non-Final OA 61d Pending May 01, 2023
18304843 Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias The Trustees of the University of Pennsylvania KELLY, ROBERT M 1638 §112 Final Rejection 26d overdue Pending Apr 21, 2023
18248192 SYSTEM INCLUDING A SERVER SYSTEM, A PLURALITY OF GATEWAYS AND A PLURALITY OF OBJECTS Moeco Iot Inc. BILODEAU, DAVID 2648 §103 Final Rejection 134d overdue Pending Apr 06, 2023
18295446 ALL-OPTICAL VISUALIZATION OF SPECIFIC MOLECULES IN THE ULTRASTRUCTURAL CONTEXT OF BRAIN TISSUE Yale University DOWNES, NATHANAEL JASON §102§103 Non-Final OA Pending Apr 04, 2023
18029422 MEDICAL PORT PROTECTION ADAPTERS Thomas Jefferson University RADOMSKI, MARTIN ADAM 3783 §102§103§112 Final Rejection Pending Mar 30, 2023
18024142 TELEMEDICINE SYSTEM Medaica Inc. TU, AURELIE H 3791 §103 Final Rejection Pending Mar 01, 2023
18174434 WALLET STEERING: SYSTEM, ENGINE, METHOD, AND PROFESSIONAL SERVICES TO PROGRAMMATICALLY, PRECISELY, AND PROFITABLY STEER CONSUMER PURCHASES FROM ONE BUSINESS TO ANOTHER AND/OR ONE PRODUCT/SERVICE TO ANOTHER, AND/OR ONE PAYMENT TENDER TO ANOTHER Stuzo, LLC PUJOLS-CRUZ, MARJORIE 3624 §101§103 Final Rejection 29d Pending Feb 24, 2023
18042993 Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting Yale University KIM, SEONG JONG 1621 §103§112 Non-Final OA 4d overdue Pending Feb 24, 2023
18041298 Green Closed Loop Bio-waste Refining Process For Producing Smart Active Extracts and Delivery Systems for Their Application Cellacure LLC PAK, JOHN D 1699 §102§103§112 Non-Final OA Pending Feb 10, 2023
18161712 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins Yale University LEE, JIA-HAI 1658 §103DPOther Non-Final OA Pending Jan 30, 2023
18091615 OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME Rowan University HELM, CARALYNNE E 1615 §103§112 Final Rejection Pending Dec 30, 2022
18088575 COMPUTER IMPLEMENTED METHOD FOR THE AUTOMATED ANALYSIS OR USE OF DATA UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED SAINT CYR, LEONARD 2658 §101 Final Rejection 14d Pending Dec 25, 2022
18088596 COMPUTER IMPLEMENTED METHOD FOR THE AUTOMATED ANALYSIS OR USE OF DATA UNLIKELY ARTIFICIAL INTELLIGENCE LIMITED ARMSTRONG, ANGELA A 2659 §101Other Final Rejection Pending Dec 25, 2022
18003125 Compositions and Methods for Selective Detection and/or Inhibition of Bacterial Pathogens in Microbial Communities Yale University BREEN, KIMBERLY CATHERINE 1657 §103§112 Final Rejection 10d overdue Pending Dec 22, 2022
18002710 PanK Modulators and Methods Using Same Yale University VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §102§103§112Other Non-Final OA 40d Pending Dec 21, 2022
18002477 Methods of Treating, Ameliorating, Shortening Duration, and/or Reversing Symptoms and/or Complications of a Coronavirus Infection Yale University RZECZYCKI, PHILLIP MATTHEW 1625 §103 Final Rejection 29d Pending Dec 19, 2022
18011106 METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS The Regents of the University of Colorado ROSWELL, JESSICA MARIE 1767 §103 Non-Final OA Pending Dec 16, 2022
18009618 Holographic Recording Materials and Methods of Making Same The Regents of the University of Colorado ANGEBRANNDT, MARTIN J 1737 §103 Non-Final OA Pending Dec 09, 2022
18000957 COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS Yale University MOLOYE, TITILAYO 1632 §103DP Final Rejection Pending Dec 07, 2022
18000644 Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis The Trustees of the University of Pennsylvania MIKNIS, ZACHARY J 1658 §102§103§112 Non-Final OA 26d Pending Dec 02, 2022
17928228 WAX-LIKE FORMULATIONS OF NATURAL-ORIGIN MATERIALS AND ITS METHOD OF PREPARATION Industrias Alen, S.A. De C.V. LIOTT, CAROLINE DUSHECK 1732 §103§112 Non-Final OA 22d overdue Pending Nov 28, 2022
17999324 AN INTEGRATED DIELECTROPHORESIS-TRAPPING AND NANOWELL TRANSFER APPROACH TO ENABLE DOUBLE-SUB-POISSON SINGLE-CELL RNA-SEQUENCING Yale University CHUNDURU, SURYAPRABHA 1681 §103 Non-Final OA 9d overdue Pending Nov 18, 2022
18056505 GAS HEATER Tutco, LLC KHLOK, BONITA 3761 §103 Non-Final OA Pending Nov 17, 2022
17985490 DYNAMIC GENERATION OF A STOCK PORTFOLIO GENERATED BY SOCIAL MEDIA CONTENT Matty Investments, LLC BUI, TOAN D. 3693 §101§103 Final Rejection Pending Nov 11, 2022
17980435 BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM CHERNYSHEV, OLGA N 1675 §101 Non-Final OA 28d Pending Nov 03, 2022
17997742 METHODS FOR DETECTION OF PATHOGENIC INFECTIONS USING RED BLOOD CELL-CONTAINING PATIENT SAMPLES The Trustees of the University of Pennsylvania KINSEY WHITE, NICOLE ERIN 1672 §103 Final Rejection Pending Nov 02, 2022
18050272 AML ANTIGENS AND USES THEREOF Kling Biotherapeutics B.V. HASAN, KHALEDA B 1636 §103§112DP Final Rejection Pending Oct 27, 2022
17997298 COMPOSITIONS AND METHODS OF ADAMTS13 CHIMERIC AUTOANTIBODY RECEPTOR CELLS The Trustees of the University of Pennsylvania JOHANSEN, PETER N. 1644 §103DPOther Non-Final OA 78d Pending Oct 27, 2022
17920663 Compounds and Compositions for Treating Hematologic Malignancies BARUCH S. BLUMBERG INSTITUTE BURKETT, DANIEL JOHN 1600 §112 Final Rejection Pending Oct 21, 2022
17938428 COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAS) Thomas Jefferson University BOESEN, CHRISTIAN C 1684 §101§112 Non-Final OA Pending Oct 06, 2022
17995072 METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISEASES AND DISORDERS Yale University MI, QIUWEN 1655 §103§112 Final Rejection Pending Sep 29, 2022
17915838 METHODS FOR TREATING, AMELIORATING, OR PREVENTING VIRAL INFECTIONS Thomas Jefferson University TOWNSLEY, SARA ELIZABETH 1629 §112 Non-Final OA Pending Sep 29, 2022
17933049 Chimeric Antigen Receptors Comprising Interleukin-9 Receptor Signaling Domain The Board Of Trustees Of The Leland Stanford Junior University GUSTILO, ESTELLA M 1646 §103DP Final Rejection Pending Sep 16, 2022
17933052 Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune Cells The Board Of Trustees Of The Leland Stanford Junior University PATTERSON, SARAH COOPER 1675 DP Final Rejection Pending Sep 16, 2022
17932466 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME VANDERBILT UNIVERSITY ROMERO, KRISTEN WANG 1626 §112DP Non-Final OA Pending Sep 15, 2022
17796570 COMPOSITIONS AND METHODS OF USING CYANINE DYES TO TARGET CANCER AND MITOCHONDRIA Thomas Jefferson University NOLAN, JASON MICHAEL 1623 §103§112 Final Rejection Pending Jul 29, 2022
17862622 COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS Spark Therapeutics, Inc. ABBOTT, KODYE LEE 1634 §112 Final Rejection 15d overdue Pending Jul 12, 2022
17792101 COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY Yale University RAMIREZ, DELIA M 1652 §102§103 Final Rejection Pending Jul 11, 2022
17782914 COMPOSITIONS AND METHODS FOR PREVENTING RECURRENCE OF CANCER Yale University BOECKELMAN, JACOB A 1655 §102DP Final Rejection Pending Jun 06, 2022
17756212 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ISCHEMIA-REPERFUSION INJURY AND/OR LUNG INJURY Yale University SCHMITT, MICHAEL J 1629 §102Other Non-Final OA 20d Pending May 19, 2022
17776829 Preservation Of Neuron Health And Regenerative Capacity Following Nervous System Injury The United States Department of Veterans Affairs CHERNYSHEV, OLGA N 1633 §103§112 Final Rejection Pending May 13, 2022
17776922 METHODS OF INDUCING OR ENHANCING FARNESOID X RECEPTOR (FXR)-MEDIATED TRANSCRIPTIONAL RESPONSE Yale University CHANDRAKUMAR, NIZAL S 1625 §103 Final Rejection Pending May 13, 2022
17769858 Lipid and Lipid Nanoparticle Formulation for Drug Delivery The Trustees of the University of Pennsylvania GONZALEZ, LUISALBERTO 1626 §112DP Non-Final OA Pending Apr 18, 2022
17768166 TARGETED BIFUNCTIONAL DEGRADERS Yale University GOTFREDSON, GAREN 1619 §103§112 Non-Final OA 30d overdue Pending Apr 11, 2022
17768145 ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS Yale University HIBSHMAN, SARAH GRACE 1693 §103§112DP Final Rejection 70d overdue Pending Apr 11, 2022
17761020 METHODS OF TREATING PHOSPHATE CONCENTRATION DISORDERS WITH L-BAIBA BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM DAHLIN, HEATHER RAQUEL 1629 §103§112 Final Rejection 77d overdue Pending Mar 16, 2022
17654984 ENGINEERED ANTIBODIES AS MOLECULAR DEGRADERS THROUGH CELLULAR RECEPTORS Yale University HIBSHMAN, SARAH GRACE 1693 §103§112Other Non-Final OA 23d overdue Pending Mar 15, 2022
17693011 Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same The United States Department of Veterans Affairs PERREIRA, MELISSA JEAN 1618 §102§103DP Non-Final OA Pending Mar 11, 2022
17687376 SYSTEMS AND METHODS FOR BARCODING CELLS AND CELL BEADS 10X Genomics, Inc. CASH, KAILEY ELIZABETH 1683 §102§103Other Non-Final OA Pending Mar 04, 2022
17637004 METHODS FOR ENHANCING DNA DAMAGE AND APOPTOSIS OF LEUKEMIC CELLS Thomas Jefferson University SIMMONS, CHRIS E 1622 §112 Final Rejection Pending Feb 21, 2022
17628106 Modulators of Excitatory Amino Acid Transporters and Methods Using Same Drexel University KUCHARCZK, JED A 1623 §102 Non-Final OA 92d overdue Pending Jan 18, 2022
17625683 COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2 ANTIBODY Yale University PETRASH, HILARY ANN 1644 §102§112DP Final Rejection Pending Jan 07, 2022
17646581 PROTEIN STABILIZED LIPOSOMES (PSL) AND METHODS OF MAKING THEREOF Lipotope, LLC CRUM, MARY ABOU NADER 1657 §103§112Other Non-Final OA 77d overdue Pending Dec 30, 2021
17528714 COMPOSITIONS AND METHODS FOR TREATING CANCER Fondazione Irccs Istituto Nazionate Dei Tumori NICKOL, GARY B 1643 §103 Non-Final OA 2d overdue Pending Nov 17, 2021
17611309 Methods and Compositions for Treating Obesity and/or Skin Disorders The Trustees of the University of Pennsylvania CHEN, PO-CHIH 1621 §112 Final Rejection Pending Nov 15, 2021
17516492 SYSTEM AND METHOD FOR ENABLING EFFICIENT DIGITAL MARKETING ON PORTABLE WIRELESS DEVICES FOR PARTIES WITH LOW CAPABILITIES Grandpad, Inc. ANDREI, RADU 3698 §101§103§112 Non-Final OA 10d overdue Pending Nov 01, 2021
17602949 Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins The Trustees of the University of Pennsylvania EDGINGTONGIORDANO, FRANCESCA 1643 §102§103DP Non-Final OA 37d overdue Pending Oct 11, 2021
17602277 METHODS AND COMPOSITIONS FOR PROGRAMMING T CELL DIFFERENTIATION AND ENHANCING T CELL PROLIFERATION The Trustees of the University of Pennsylvania WESTON, ALYSSA G 1633 §102§103 Final Rejection Pending Oct 07, 2021
17593475 METHODS, COMPUTER-READABLE MEDIA, AND SYSTEMS FOR ASSESSING WOUNDS AND CANDIDATE TREATMENTS Drexel University LUO, JAMMY NMN 1686 §101§103 Non-Final OA Pending Sep 20, 2021
17445285 ENHANCING SUBCUTANEOUS INJECTION AND TARGET TISSUE ACCUMULATION OF NANOPARTICLES VIA CO-ADMINISTRATION WITH MACROPINOCYTOSIS INHIBITORY NANOPARTICLES (MINP) Northwestern University WESTERBERG, NISSA M 1618 §103 Final Rejection 28d overdue Pending Aug 17, 2021
17427180 DEVICES AND METHODS FOR MEASURING BRAIN STATE Wisconsin Alumni Research Foundation COOPER, JONATHAN EPHRAIM 3791 §103 Final Rejection 29d Pending Jul 30, 2021
17348988 ROBOTIC PRODUCTION ENVIRONMENT FOR VEHICLES Arrival Ltd. CULLEN, TANNER L 3656 §103 Non-Final OA 121d overdue Pending Jun 16, 2021
17291869 Engineering Of Innervated Tissue And Modulation Of Peripheral Organ Activity The United States Department of Veterans Affairs STAVROU, CONSTANTINA E 1632 §103§112 Final Rejection Pending May 06, 2021
17222216 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS WHICH RELATE TO TRAVEL ARRANGEMENTS Skyscanner Limited WALSH, EMMETT K 3628 §101 Final Rejection 79d overdue Pending Apr 05, 2021
17193907 PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS University Of North Texas Health Science Center AT Fort Worth HANEY, AMANDA MARIE 1682 §112DPOther Final Rejection 69d Pending Mar 05, 2021
17189970 MOBILIZED PERIPHERAL BLOOD AS A SOURCE OF MODIFIED IMMUNE CELLS The Trustees of the University of Pennsylvania MIDDLETON, DANAYA L 1674 §103§112 Non-Final OA 18d overdue Pending Mar 02, 2021
17168638 PSYCHEDELIC TREATMENT FOR HEADACHE DISORDERS The United States Department of Veterans Affairs COPPINS, JANET L 1628 §103 Final Rejection Pending Feb 05, 2021
15734382 COMPUTER IMPLEMENTED METHOD AND SYSTEM FOR UPDATING A DATABASE SYSTEM FOR A BLOCKCHAIN VERSION CONTROL SYSTEM; COMPUTER IMPLEMENTED METHODS OF AUCTIONING AN ITEM FOR A SELLER, AND COMPUTER IMPLEMENTED METHOD OF UPDATING A SMART CONTRACT Perpetual Altruism Limited KHATRI, NILESH B 3699 §101§103 Non-Final OA Pending Dec 02, 2020
17046253 Methods And Compositions Comprising A Viral Vector For Expression Of A Transgene And An Effector The Trustees of the University of Pennsylvania VIVLEMORE, TRACY ANN 1638 §103§112 Non-Final OA Pending Oct 08, 2020
16971995 METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC The Trustees of the University of Pennsylvania CONNORS, ALEXANDRA F 1634 §103§112 Final Rejection Pending Aug 21, 2020
16629264 METHODS FOR DIAGNOSING PANCREATIC CANCER Mayo Foundation for Medical Education and Research DENT, ALANA HARRIS 1643 §103 Non-Final OA Pending Jan 07, 2020
16485550 LIGHT GUIDE DEVICE AND DISPLAY DEVICE FOR REPRESENTING SCENES Seereal Technologies S.A. WILKES, ZACHARY W 2872 §103§112 Final Rejection 13d Pending Aug 13, 2019

Managing Saul Ewing LLP (Philadelphia)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month